Rapid improvement of intracranial tuberculomas after addition of ofloxacin to first-line antituberculosis treatment.

Reported here is the case of a 9-year-old girl presenting with disseminated tuberculosis, the manifestations of which included mediastinal adenopathy, an osteolytic parietal lesion with a large associated scalp abscess, cerebral empyema, meningoencephalitis, and tuberculomas. No clear improvement was observed after 4 weeks of first-line antituberculosis treatment (10 mg/kg rifampin, 15 mg/kg isoniazid, 30 mg/kg ethambutol, 30 mg/kg pyrazinamide). The isolation of an isoniazid-resistant organism prompted institution of ofloxacin. Introduction of this drug was associated with dramatic improvement. Its good penetration into the central nervous system and its distribution into macrophages suggest that this drug may be of interest for the treatment of intracranial tuberculomas, particularly those due to isoniazid-resistant strains.
AuthorsI Sermet-Gaudelus, F Stambouli, V Abadie, F Goutières, G Lenoir, D Gendrel, J L Gaillard
JournalEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (Eur J Clin Microbiol Infect Dis) Vol. 18 Issue 10 Pg. 726-8 (Oct 1999) ISSN: 0934-9723 [Print] GERMANY
PMID10584900 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Infective Agents
  • Ofloxacin
  • Anti-Infective Agents (therapeutic use)
  • Child
  • Female
  • Humans
  • Ofloxacin (therapeutic use)
  • Tuberculoma, Intracranial (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: